The investigators hypothesize that occlusion myocardial infarction(MI)/non-occlusion MI approach to MI treatment will better predict acute coronary occlusion on coronary angiography, better limit infarct size, better preserve left ventricular function and result in lower long-term adverse cardiac events (all cause mortality, all cause rehospitalization) compared to standard ST-elevation/non-ST-elevation MI paradigm.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary end point: Major adverse events (Mortality and rehospitalization)
Timeframe: One year
Primary end point: Major adverse events (Mortality and rehospitalization) in STEMI (-) OMI (+) subgroup
Timeframe: One year